Furthermore, an in vitro study showed that FGF21 supplement protected the cardiomyocytes against lipotoxicity rather than glucose toxicity, indicating that FGF21-induced cardiac protection in T2DM mice is mainly attributed to the prevention of lipotoxicity rather than hyperglycemia. This evidence concerns the gene FGF21 and Hyperglycemia.